China, the National Medical Products Administration (NMPA), announced the on April 29, 2024, to strengthen supervision and standardize the inspection of cosmetics and implemented it on November 1, 2024. The key points of the Cosmetics Inspection and Management Methods are as follows: 1) Inspection Subjects:- Cosmetics manufacturers, operators, and other relevant entities and individuals subject..

2024年10月30日、中国国家医薬品監督管理総局(NMPA)は化粧品安全性に関する技術規格(2015)をアップデートしました。 更新された内容は、化粧品に含まれる「アゼラ酸及びその塩類の試験方法」を含む5つの試験方法が、化粧品の安全性に関する技術規格（2015）に含まれるものです。 化粧品の安全性に関する技術規格(2015)の5つの基準の制定および改正内容の要約は以下の通りです。 No.Test ItemImplementation DateNew / Revised 1Test Methods for Azelaic Acid and Its Salts in CosmeticsJuly 1, 2025New2Test Methods for Phenacetin in Cosmetics3Test Methods for Hydroxydecanoic Acid Cosmetic..

On November 4, 2024, China’s National Medical Products Administration (NMPA) approved the registration of a new cosmetic ingredient, Isobutylamido Thiazoyl Resorcinol (Thiamidol 630).  This ingredient is the first to be registered since the implementation of the Cosmetics Supervision and Administration Regulation (CSAR) in 2021. It has been verified for its efficacy and safety by the registratio..

On October 30, 2024, the National Medical Products Administration (NMPA) of China updated the Safety and Technical Standards for Cosmetics (2015). The update includes the addition of five testing methods, one of which is for the “Test Methods for Azelaic Acid and its Salts in cosmetics”These new and revised standards are now incorporated into the 2015 edition of the Safety and Technical Standard..

The National Medical Products Administration (NMPA) of China issued the Regulations on July 8, 2024 to steadily promote the relevant work of high-frequency treatment devices and high-frequency skin treatment devices, and take into account the requirements of public equipment safety and orderly development of the industry. Annex 09-07-02 of the “Notice on Partial Adjustment of the Medical Device ..

NMPA announced “notice on improving cosmetics safety evaluation and management measures” on April 22, 2024 to further optimize cosmetics safety evaluation and management and to promote orderly implementation of the cosmetics safety evaluation system. This announcement will take effect from May 1, 2024. The contents of the notice, which will take effect from May 1, 2024, are as follows. 1. Classi..

The CMDE under the National Medical Products Administration (NMPA) of China has issued guidelines for registration and review of high-frequency beauty devices (No. 8[2023]). Manufacturers of radio frequency beauty devices classified as Class III will have to comply with the new technical review guidelines from April 1, 2024. The High Frequency beauty device Registration and Review Guidelines (No..

On February 17, 2023, the NMPA in China made an announcement on the implementation of the 3rd Unique Device Identification (UDI) of medical devices. Depending on the degree of risk and regulatory needs, some Class2 medical devices, such as disposable products with high clinical demand, products selected for mass supply, and medical beauty-related products, are determined to be in the third batch..

The Hong Kong Medical Device Division (MDD) has announced that the “Essential Principles of Medical Device Safety and Performance” (Technical Reference: TR-004) will be available for use in the Medical Device Administrative Control System (MDACS) from 1 January 2024. Hong Kong's existing reference countries were Australia, Canada, the European Union, Japan, and the United States, but as the info..

China medical industry is still growing rapidly. As of 2022, the Chinese medical device market was 1.3 trillion yuan, growing 6.1 in size compared to 2013. The Chinese medical device market has a global market share of 27.5%, with an average annual growth rate of more than 12% over the past five years. China is a market that cannot be abandoned despite its policy of using domestic medical device..